01 1Viatris
01 1LINAGLIPTIN
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2014-12-22
Pay. Date : 2014-10-30
DMF Number : 28748
Submission : 2014-10-31
Status : Active
Type : II
20
Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LINAGLIPTIN, with a corresponding US DMF Number 28748.
Remarkably, this DMF maintains an Active status since its submission on October 31, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 22, 2014, and payment made on October 30, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II
